WaveMan · Form 4
Craig Adam R insider trades
> Search tickers & screens ⌘K
LIVE

Craig Adam R insider trades

Craig Adam R has filed 16 Form 4s with the SEC that we hold, for CTIC (President and CEO, Director) and X4 Pharmaceuticals, Inc (XFOR) (Executive Chairman, Director). Across all of them we count 4 purchases worth $282.8K and 25 sales worth $5.3M reported on Form 4. In the last 12 months: 1 purchase ($250.0K) and 1 sale ($210.8K). The largest single trade was a sale of 242,300 shares of CTIC worth $1.6M, dated 2022-09-12. The first filing on our record is dated 2021-12-02 and the latest 2026-08-13.

CTIC

President and CEO, Director · 12 filings · 27 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-02P, purchase reported on Form 42,178$3.3K2021-12-02
2021-12-02P, purchase reported on Form 41,322$2.0K2021-12-02
2022-06-01S, sale reported on Form 427,000$162.0K2022-06-03
2022-06-02S, sale reported on Form 427,000$162.0K2022-06-03
2022-06-03S, sale reported on Form 418,223$109.5K2022-06-03
2022-07-01S, sale reported on Form 427,000$162.0K2022-07-06
2022-07-05S, sale reported on Form 427,000$162.0K2022-07-06
2022-07-06S, sale reported on Form 418,223$111.3K2022-07-06
2022-08-16P, purchase reported on Form 45,000$27.5K2022-08-16
2022-09-12S, sale reported on Form 4242,300$1.6M2022-09-14
2022-11-09S, sale reported on Form 446,100$276.6K2022-11-14
2022-11-09S, sale reported on Form 47,596$45.7K2022-11-14
2022-11-09S, sale reported on Form 4300$1.8K2022-11-14
2022-11-10S, sale reported on Form 45,800$35.0K2022-11-14
2022-11-10S, sale reported on Form 42,700$16.3K2022-11-14
2022-11-10S, sale reported on Form 4136,408$818.4K2022-11-14
2022-11-10S, sale reported on Form 4200$1.2K2022-11-14
2022-11-10S, sale reported on Form 426,700$160.5K2022-11-14
2022-11-10S, sale reported on Form 4100$6022022-11-14
2022-11-10S, sale reported on Form 416,396$98.7K2022-11-14
2022-12-29S, sale reported on Form 413,800$82.8K2023-01-03
2022-12-30S, sale reported on Form 44,400$26.4K2023-01-03
2022-12-30S, sale reported on Form 4700$4.2K2023-01-03
2022-12-30S, sale reported on Form 412,000$72.0K2023-01-03
2023-01-03S, sale reported on Form 484,683$508.9K2023-01-03
2023-01-24S, sale reported on Form 42,117$12.7K2023-01-26
2023-01-24S, sale reported on Form 483,200$499.2K2023-01-26

X4 Pharmaceuticals, Inc (XFOR)

Executive Chairman, Director · 4 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-23P, purchase reported on Form 486,206$250.0K2025-10-27
2026-08-12S, sale reported on Form 447,436$210.8K2026-08-13
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1339498) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms